# Tyto Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tyto-care

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.tytocare.com
- Total disclosed funding: $157M
- Latest round: Series D (Mar 4, 2021)
- Investors on record: 18

## About

Based in New York, US, and founded in 2011 by Dedi Gilad (CEO) and Ofer Tzadik (COO), Tyto Care Ltd., formerly known as Eon-Medical operates as a developer of a modular device and telehealth platform for AI-powered, on-demand remote medical examinations that enable users to replicate a face-to-face visit to the physician. In August 2023, Tyto Care Ltd. raised USD 49 million in growth funding led by Insight Partners, with participation from Clal Biotechnology, Healthcare of Ontario Pension Plan, and MemorialCare Innovation Fund.

Tyto Care is a telehealth company that developed a remote device built for examination and consultation with physicians. The company's offering combines a handheld device, an all-in-one tool for examining the heart, lungs, skin, ears, throat, abdomen, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use for patients and insights for healthcare providers. 

The company, which has FDA and CE clearances, has partnered with over 150 health organizations and insurers, with 6,000 physicians currently using the telehealth solution.

Tyto Care intends to use the August 2023 funding to support the improvement of its product offerings and artificial intelligence capabilities.

## Funding rounds

- Series D, Mar 4, 2021, $50M — Insight Partners, Tiger Global Management, Qualcomm Ventures, Qumra Capital, OTV, Shenzhen Capital Real Estate Fund
- Series D, Apr 7, 2020, $50M — OrbiMed Advisors, Insight Partners, Teuza, Qualcomm Ventures, OTV, Echo Health Ventures, Qure Ventures
- Series C, Jan 16, 2019, $9M — Itochu, Sanford Health, Ping An Global Voyager Fund, Shenzhen Capital Real Estate Fund
- Series C, Jan 28, 2018, $27M — OrbiMed Advisors, Itochu, Walgreen Co., Fosun International, Cambia Health Solutions, LionBird, MTIP, Ping An Global Voyager Fund, Qure Ventures
- Series B, Jul 14, 2015, $12M — OrbiMed Advisors, Teuza, Walgreen Co., Fosun International, Cambia Health Solutions, LionBird
- Series A, Mar 17, 2014, $7M — OrbiMed Advisors, Walgreen Co., Fosun International, LionBird
- Seed, Jul 1, 2012, $1.5M — Teuza

## Investors

- Teuza (https://capitalatlas.ai/funds/teuza) — Seed, Series B, Series D
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A, Series B, Series C, Series D
- Walgreen Co. — Series A, Series B, Series C
- Fosun International (https://capitalatlas.ai/funds/fosun-international) — Series A, Series B, Series C
- LionBird (https://capitalatlas.ai/funds/lionbird) — Series A, Series B, Series C
- Cambia Health Solutions — Series B, Series C
- Itochu — Series C
- MTIP (https://capitalatlas.ai/funds/mtip) — Series C
- Ping An Global Voyager Fund (https://capitalatlas.ai/funds/ping-an-global-voyager-fund) — Series C
- Qure Ventures (https://capitalatlas.ai/funds/qure-ventures) — Series C, Series D
- Sanford Health — Series C
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series C, Series D
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series D
- Qualcomm Ventures (https://capitalatlas.ai/funds/qualcomm-ventures) — Series D
- OTV (https://capitalatlas.ai/funds/otv) — Series D
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series D
- Tiger Global Management (https://capitalatlas.ai/funds/tiger-global-management) — Series D
- Qumra Capital (https://capitalatlas.ai/funds/qumra-capital) — Series D